Skip to main content
Clinical Trials/ISRCTN17993825
ISRCTN17993825
Completed
N/A

A randomised controlled trial of the clinical and cost-effectiveness of the Journeying through Dementia intervention compared to usual care

Sheffield Health & Social Care NHS Foundation Trust0 sites519 target enrollmentOctober 11, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Specialty: Dementias and neurodegeneration, Primary sub-specialty: Dementia
Sponsor
Sheffield Health & Social Care NHS Foundation Trust
Enrollment
519
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33574660/ qualitative study results (added 15/02/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33573589/ fidelity assessment (added 18/02/2021) 2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/31996259/ trial challenges (added 18/02/2021) 2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31519673/ protocol (added 18/02/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34114132/ DEMQOL instrument results (added 14/06/2021) 2022 Results article in https://doi.org/10.1016/S2666-7568(22)00059-9 Efficacy results (added 08/04/2022) 2022 Funder report results in https://pubmed.ncbi.nlm.nih.gov/35536231/ (added 11/05/2022)

Registry
who.int
Start Date
October 11, 2016
End Date
November 30, 2019
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sheffield Health & Social Care NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • People with dementia:
  • 1\. People diagnosed with dementia for example Alzheimer’s disease, vascular dementia or mixed Alzheimer’s/vascular dementia
  • 2\. A Mini Mental State Examination (MMSE) score of 18 or over (conducted less than 2 months pre consent)
  • 3\. Can make informed decisions (assessed by the Capacity Assessment Form)
  • 4\. Living in the community or in sheltered accommodation, alone or with others
  • 5\. Able to converse and communicate in English
  • 6\. Willing to engage in a 12 week group self\-management intervention
  • Supporters (carers of a person with dementia):
  • 1\. Aged 18 years or older
  • 2\. Named by the person with dementia as their supporter

Exclusion Criteria

  • People with dementia:
  • 1\. Not been diagnosed with a form of dementia
  • 2\. Being in more moderate stages of dementia. Measured by having a MMSE score of \< 18
  • 3\. Is assessed as lacking capacity (assessed by the Capacity Assessment Form)
  • 4\. Living in residential or nursing care
  • 5\. Not able to converse or communicate in English
  • 6\. Is taking part in any other pharmacological or psychosocial intervention studies
  • Supporters:
  • 1\. Under 18 years old
  • 2\. The person with dementia they provide support to is not participating in the trial

Outcomes

Primary Outcomes

Not specified

Similar Trials